Krishna Institute of Medical Sciences Fair Value
Krishna Institute of Medical Sciences fair value. Krishna Institute of Medical Sciences (KIMS) average fair value is ₹292.53 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹767.8 (-61.9%), fair value range ₹31.32–₹898.85. For live price and a broader fundamental view, visit Krishna Institute of Medical S share price today.
Fair Value Analysis Export
KIMS Fair Value vs Current Price — Valuation Summary
KIMS average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Analyse KIMS shareholder distribution to track promoter, FII and institutional holdings.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
KIMS Fair Value Analysis — Data Sources & Coverage
Krishna Institute of Medical Sciences financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
KIMS vs Healthcare Sector Peers — P/E, P/B & Market Cap
Krishna Institute of Medical Sciences P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Pharmaids Pharmaceuticals | PHARMAID | -28.7 | 2.2 | ₹100 |
| Modern Diagnostic & Rese… | MDRC | - | 1.42 | ₹83 |
| Broach Lifecare Hospital | BROACH | 90.7 | 0.82 | ₹8 |
| Emcure Pharmaceuticals | EMCURE | 40.6 | 8.3 | ₹44,381 |
| Glen Industries | GLEN | 15.7 | 1.97 | ₹250 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.